Drug
Antineoplaston A10 clinical trials
Also written Atengenal.
Keep track of what changes. Save the antineoplaston A10 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 1996 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 1996 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 5
Burzynski Research Institute (5)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses antineoplaston A10 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem GliomaNot yet recruitingPhase 3Burzynski Research InstituteNCT02864888Written as Atengenal
- Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem GliomaNot yet recruitingPhase 3Burzynski Research InstituteNCT02887040Written as Atengenal
- Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed GliomasCompletedPhase 2Burzynski Research InstituteNCT00003473Written as Atengenal
- Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon CancerTerminatedPhase 2Burzynski Research InstituteNCT00003485Written as antineoplaston A10, antineoplaston AS2-1 (ANP)
- Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast CancerWithdrawnPhase 2Burzynski Research InstituteNCT00003536Written as antineoplaston A10
Codes
What other systems call antineoplaston A10 · ClinicalTrials.gg INT003321
- MeSH (NLM) C052091antineoplaston A10Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) 16VY3TM7ZOANTINEOPLASTON A10Confirmed FDA, NLM, Wikidata
- Wikidata Q27251844antineoplaston a10Confirmed FDA, NLM, Wikidata
- NCI Thesaurus C1004Antineoplaston A10One source FDA
- DrugBank DB11702One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C052091 | antineoplaston A10 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 16VY3TM7ZO | ANTINEOPLASTON A10 | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27251844 | antineoplaston a10 | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1004 | Antineoplaston A10 | One source FDA |
| DrugBank | DB11702 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.